Weight gain and metabolic issues of medicines used for bipolar disorder.
Patients with bipolar disorder are at high risk of gaining weight and developing metabolic illnesses, and pharmacologic treatment for the disorder may significantly increase this risk. This paper reviews the literature on the metabolic consequences of the medications used in bipolar disorder and describes the possible strategies to prevent, monitor, and treat the common metabolic illnesses that patients with bipolar disorder may develop during treatment.
Fagiolini
Andrea
A
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-2593, USA. Fagiolinia@upmc.edu
Chengappa
K N Roy
KN
D018692:Antimanic Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D009765:Obesity / Q000139:chemically induced* / Q000453:epidemiology*; D015430:Weight Gain / Q000187:drug effects*
D018692:Antimanic Agents; D014150:Antipsychotic Agents